Towards Healthcare
Embolization Particles Market Expands at 12.27% CAGR by 2034

Embolization Particles Market Competitive Forces and Top Key Players

Based on market forecasts, the embolization particles sector will expand from USD 1.19 billion in 2024 to USD 3.79 billion by 2034, experiencing a CAGR of 12.27%. The market is driven by growing demand for minimally invasive procedures and rising technological advancements like drug-eluting beads in chemotherapy. However, North America dominated the market with a major share due to the increasing instances of cancer, stroke, and peripheral vascular conditions, and advanced healthcare infrastructure.

Content

  • Insight Code: 5790
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: June 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Rohan Patil is a seasoned market research professional with over 5 years of focused experience in the healthcare sector, bringing deep domain expertise, strategic foresight, and analytical precision to every project he undertakes.

He began his journey with Precedence Research, where he played a pivotal role in developing high-impact healthcare market reports. Today, Rohan leads research initiatives at Towards Healthcare, while also contributing to Statifacts, where he supports cross-industry analysis and data-driven storytelling.

Rohan’s core strengths lie in trend analysis and emerging technologies, regulatory monitoring and thought leadership through high-quality report writing. He excels at identifying future-ready opportunities and translating complex data into strategic recommendations. His work spans pharmaceuticals, biotechnology, medical devices, and digital health, assessing everything from market potential and competitive positioning to customer needs and regulatory shifts.

A trusted advisor and a relentless innovator, Rohan continues to push the boundaries of traditional market research, merging scientific rigor with commercial insight to stay ahead in a fast-evolving healthcare landscape.

Talk to us
FAQ's

The embolization particles market is projected to reach USD 3.79 billion by 2034, growing at a CAGR of 12.27% from 2024 to 2034.

North America is currently leading the embolization particles market due to the higher cases of cancer, stroke, and peripheral vascular conditions, and advanced healthcare infrastructure.

The embolization particles market includes 3 segments, such as by product type, by application, and by region etc.

Some key players include Boston Scientific Corporation, Cook Medical, Merit Medical Systems, Sirtex Medical, and BTG plc.

Key trends include rising demand for minimally invasive procedures, growth in applications in oncology and peripheral vascular disease, and innovation in embolic agents and other targeted treatments.

They are made of Polyvinyl alcohol (PVA), Gelatin sponge, Drug-eluting beads, Tris-acryl gelatin, and polyzene-F hydrogel.

The main purpose of embolization is to employ to stop bleeding or to block the flow of blood to a tumor or abnormal area of tissue.

The advantages of using DEBs in TACE are targeted delivery, sustained release, reduced toxicity, and enhanced outcomes.

NIH.GOV, CDC.GOV, GOV.UK, US FDA.GOV, MEDLINEPLUS.GOV, NCI.GOV
Any Questions